Can oxygen chambers boost heart failure treatment?

NCT ID NCT07311109

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard heart failure medications can help people with chronic heart failure walk farther and improve heart function. About 150 adults with reduced heart pumping ability will be randomly assigned to receive either standard drugs alone or standard drugs plus oxygen sessions. The main goal is to see if the oxygen therapy safely increases walking distance in six minutes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.